Zosano Pharma, Inc. is a private biopharmaceutical company developing products based on our novel transdermal delivery technology. Our lead product, ZP-PTH which is preparing to enter a phase 3 pivotal trial for the treatment of severe osteoporosis is based on our ZP Patch Technology, a proprietary transdermal delivery technology capable of delivering peptides, proteins, small molecules and vaccines. We are developing products with significant commercial potential both independently and in collaboration with strategic partners.